首页|肿瘤标志物定量检测试剂监管现状及技术审评关注点介绍

肿瘤标志物定量检测试剂监管现状及技术审评关注点介绍

扫码查看
肿瘤标志物定量检测试剂是目前临床应用极为广泛的一类试剂.该类试剂种类多,已上市、正在申报中以及处于开发阶段的全新产品数量也极为丰富.本文旨在系统性地对该类产品的监管现状进行阐述;同时,在参照当前相关法规及适用技术文件的基础上,结合相关审评经验,详细介绍该类试剂注册申报资料中常见的审评关注点,为相关人员提供参考.
An Introduction for the Current Regulatory Status and Technical Evaluation Focus of Tumor Marker Quantitative Detection Reagents
Tumor marker quantitative detection reagents are one type of reagents that are currently widely used in clinical practice.There are many types of such reagents,and the amount of marketed,declared and new products at the development stage is also extremely abundant.The aim of this paper is to systematically elaborate the current status of the supervision of such type of products.Furthermore,based on current relevant regulations and applicable technical documents,combined with the relevant review experience,the common review concerns in the registration and application of this type of reagent are introduced in detail to provide references for relevant personnel.

Tumor marker quantitative detection reagentsSupervisionTechnical evaluation

程曦、焦童

展开 >

国家药品监督管理局医疗器械技术审评中心,北京 100076

肿瘤标志物定量检测试剂 监管 技术审评

2024

标记免疫分析与临床
中国同辐股份有限公司

标记免疫分析与临床

CSTPCD
影响因子:0.978
ISSN:1006-1703
年,卷(期):2024.31(8)